Search

everythinglearnresearchcommunity

for

Search:↓

The ACE1 gene variant doesn't affect long-COVID symptoms.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

Women may need different blood pressure guidelines than men for heart disease prevention.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Modified PRP therapy successfully treated severe alopecia unresponsive to traditional methods.

Mesenchymal stem cells could help treat aging-related diseases better than current methods.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Severe hair loss significantly worsens quality of life.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Wearing headcovers doesn't affect male-pattern hair loss severity.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

New treatments for male hypogonadism are effective and should be personalized.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.